491 related articles for article (PubMed ID: 27477083)
41. The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.
Kudela E; Liskova A; Samec M; Koklesova L; Holubekova V; Rokos T; Kozubik E; Pribulova T; Zhai K; Busselberg D; Kubatka P; Biringer K
EPMA J; 2021 Jun; 12(2):199-220. PubMed ID: 34194585
[TBL] [Abstract][Full Text] [Related]
42. Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic Strategies.
Li Y; Yu T; Yan H; Li D; Yu T; Yuan T; Rahaman A; Ali S; Abbas F; Dian Z; Wu X; Baloch Z
Infect Drug Resist; 2020; 13():1213-1220. PubMed ID: 32431522
[TBL] [Abstract][Full Text] [Related]
43. On the Search to Elucidate the Role of Microbiota in the Genesis of Cancer: The Cases of Gastrointestinal and Cervical Cancer.
Avilés-Jiménez F; Yu G; Torres-Poveda K; Madrid-Marina V; Torres J
Arch Med Res; 2017 Nov; 48(8):754-765. PubMed ID: 29203054
[TBL] [Abstract][Full Text] [Related]
44. High risk HPV-positive women cervicovaginal microbial profiles in a Greek cohort: a retrospective analysis of the GRECOSELF study.
Sofou E; Gkoliou G; Pechlivanis N; Pasentsis K; Chatzistamatiou K; Psomopoulos F; Agorastos T; Stamatopoulos K
Front Microbiol; 2023; 14():1292230. PubMed ID: 38098662
[TBL] [Abstract][Full Text] [Related]
45. The role of the vaginal microbiome in gynaecological cancer.
Champer M; Wong AM; Champer J; Brito IL; Messer PW; Hou JY; Wright JD
BJOG; 2018 Feb; 125(3):309-315. PubMed ID: 28278350
[TBL] [Abstract][Full Text] [Related]
46. Dysbiotic Co-Factors in Cervical Cancer. How the Microbiome Influences the Development of Cervical Intraepithelial Neoplasia (CIN).
Finzer P; Küppers V; Griesser H
Geburtshilfe Frauenheilkd; 2023 Aug; 83(8):1017-1021. PubMed ID: 37588255
[TBL] [Abstract][Full Text] [Related]
47. Metabolic profiles outperform the microbiota in assessing the response of vaginal microenvironments to the changed state of HPV infection.
Dai W; Du H; Zhou Q; Li S; Wang Y; Hou J; Guo C; Yang Q; Li C; Xie S; Li SC; Wu R
NPJ Biofilms Microbiomes; 2024 Mar; 10(1):26. PubMed ID: 38509123
[TBL] [Abstract][Full Text] [Related]
48. Association between Cervical Microbiota and HPV: Could This Be the Key to Complete Cervical Cancer Eradication?
Cascardi E; Cazzato G; Daniele A; Silvestris E; Cormio G; Di Vagno G; Malvasi A; Loizzi V; Scacco S; Pinto V; Cicinelli E; Maiorano E; Ingravallo G; Resta L; Minoia C; Dellino M
Biology (Basel); 2022 Jul; 11(8):. PubMed ID: 35892970
[TBL] [Abstract][Full Text] [Related]
49. Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment.
Łaniewski P; Cui H; Roe DJ; Chase DM; Herbst-Kralovetz MM
NPJ Precis Oncol; 2020; 4():22. PubMed ID: 32802959
[TBL] [Abstract][Full Text] [Related]
50. Anticancer effect of bacteria on cervical cancer: Molecular aspects and therapeutic implications.
Pourmollaei S; Barzegari A; Farshbaf-Khalili A; Nouri M; Fattahi A; Shahnazi M; Dittrich R
Life Sci; 2020 Apr; 246():117413. PubMed ID: 32035929
[TBL] [Abstract][Full Text] [Related]
51. KF-finder: identification of key factors from host-microbial networks in cervical cancer.
Hu J; Gao Y; Zheng Y; Shang X
BMC Syst Biol; 2018 Apr; 12(Suppl 4):54. PubMed ID: 29745858
[TBL] [Abstract][Full Text] [Related]
52. Vaginal Microbiota and HPV in Latin America: A Narrative Review.
Tosado-Rodríguez E; Alvarado-Vélez I; Romaguera J; Godoy-Vitorino F
Microorganisms; 2024 Mar; 12(3):. PubMed ID: 38543670
[TBL] [Abstract][Full Text] [Related]
53. Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review).
Fernandes JV; DE Medeiros Fernandes TA; DE Azevedo JC; Cobucci RN; DE Carvalho MG; Andrade VS; DE Araújo JM
Oncol Lett; 2015 Mar; 9(3):1015-1026. PubMed ID: 25663851
[TBL] [Abstract][Full Text] [Related]
54. [The characteristics of vaginal microbiota and its correlation with cervical cancer].
Kuang L; Zhang B; Sun F; Zhang JB
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):156-160. PubMed ID: 35184476
[TBL] [Abstract][Full Text] [Related]
55. Redrawing therapeutic boundaries: microbiota and cancer.
Sholl J; Sepich-Poore GD; Knight R; Pradeu T
Trends Cancer; 2022 Feb; 8(2):87-97. PubMed ID: 34844910
[TBL] [Abstract][Full Text] [Related]
56. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?
Mitra A; MacIntyre DA; Marchesi JR; Lee YS; Bennett PR; Kyrgiou M
Microbiome; 2016 Nov; 4(1):58. PubMed ID: 27802830
[TBL] [Abstract][Full Text] [Related]
57. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota.
Shannon B; Yi TJ; Perusini S; Gajer P; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Rebbapragada A; Kaul R
Mucosal Immunol; 2017 Sep; 10(5):1310-1319. PubMed ID: 28120845
[TBL] [Abstract][Full Text] [Related]
58. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
[TBL] [Abstract][Full Text] [Related]
59. Relationship between vaginal microbial dysbiosis, inflammation, and pregnancy outcomes in cervical cerclage.
Kindinger LM; MacIntyre DA; Lee YS; Marchesi JR; Smith A; McDonald JA; Terzidou V; Cook JR; Lees C; Israfil-Bayli F; Faiza Y; Toozs-Hobson P; Slack M; Cacciatore S; Holmes E; Nicholson JK; Teoh TG; Bennett PR
Sci Transl Med; 2016 Aug; 8(350):350ra102. PubMed ID: 27488896
[TBL] [Abstract][Full Text] [Related]
60. Unraveling the Dynamics of the Human Vaginal Microbiome.
Nunn KL; Forney LJ
Yale J Biol Med; 2016 Sep; 89(3):331-337. PubMed ID: 27698617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
